Skip to main content

Bladder Cancer Academy

 

 

 

 

 

Bladder Cancer Academy ensures urology/oncology fellows, residents, and LUGPA physicians receive optimal education on bladder cancer diagnosis and management, advanced monitoring and care options, novel pharmaceutical therapies, and surgical advancements.  Invited attendees interact with the top thought leaders who play pivotal roles in advancing the treatment of prostate cancer. Our esteemed Faculty Chairs developed a comprehensive agenda addressing the most current and pressing topics in the field of bladder cancer presented as didactic lectures and case-based discussions. This program is co-sponsored by MedReviews, LLC, publishers of Reviews in Urology®, and LUGPA.

 

 

 

Cardiometabolic University

 

 

 

 

Cardiometabolic University (CMU) ensures that cardiology, nephrology, and endocrinology fellows receive intensive and multidisciplinary education on cardiometabolic disease including obesity and metabolic syndrome, diabetes, atherosclerosis, diabetic nephropathy, and diabetic cardiomyopathy. CMU presents, discusses, and debates all available preventive, diagnostic, therapeutic, and management options for cardiometabolic disease and nutrition in a highly interactive format. This program includes didactic lectures, case-based discussions, and faculty panels. This multi-sponsored program has been developed by MedReviews, LLC, publishers of Reviews in Cardiovascular Medicine.

 

 

 

Heart Failure Conference

 

 

 

 

Heart Failure University (HFU) ensures that cardiology fellows receive intensive education on heart failure prevention, diagnosis and management, advanced monitoring and care options, novel pharmaceutical therapies, mechanical assist devices, and heart transplantation. This program includes didactic lectures, case-based discussions, and faculty panels. This multi-sponsored program has been developed by MedReviews, LLC, publishers of Reviews in Cardiovascular Medicine.

 

 

 

 

 

 

 

 

Prostate Cancer Academy (PCA) ensures urology/oncology fellows, residents, and LUGPA physicians receive optimal education in prostate cancer diagnosis and management, advanced monitoring and care options, novel pharmaceutical therapies, and surgical advancements. Invited attendees interact with the top thought leaders who play pivotal roles in advancing the treatment of prostate cancer. Faculty chairs have developed a comprehensive agenda addressing the most current and pressing topics in the field of urologic oncology that will include didactic lectures, case-based discussions, and faculty panels. This program is co-sponsored by MedReviews, LLC, publishers of Reviews in Urology® and LUGPA.